CCM
SYRS

CAAS Capital Management’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History

CAAS Capital Management’s Portfolio SYRS Stock Details SYRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-1,391
Closed -$76K – 842
2021
Q2 		$76K Buy
+1,391
New +$76K ﹤0.01% 616